These compounds are used to target different nuclear receptors of cancer which includes peroxisome proliferator-activated receptor gamma (PPARγ), toll-like receptor 4 (TLR4), brain-derived neurotrophic factor (BDNF), and peroxisome proliferator-activated receptor alpha (PPARα) (13). This evidence concerns the gene PPARG and cancer.